FDA Regulation of Medical Devices, Including the Status of Breast Implants: Joint Hearing Before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, First Session, August 1, 1995
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations
U.S. Government Printing Office, 1996 - Political Science - 206 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
advisory agency American answer approval autoimmune disease Barrett believe biomaterials breast augmentation breast cancer breast reconstruction Burlington Chairman clinical cohort committee companies concern Congress Congressman connective tissue disease connective-tissue disease cosmetic decision developed documents Dow Corning Drug elastomers evaluation evidence fact FDA's Ganske going Gutknecht Hazleton hearing hydrocephalus industry issue Kessler litigation Lloyd look mammograms manufacturers McIntosh medical devices Merkatz moratorium Morella panel patients percent physicians plants plastic polyester polyethylene polyurethane polyvinylchloride Prepared Statement problem PTFE public health question Ransom raw materials reconstruction regulatory reported rheumatoid arthritis rheumatologists rupture rate Russano scientific scleroderma Shanklin Shays shunt sili silica silicone breast implants silicone gel silicone gel breast silicone gel implants silicone implants specific Subcommittee suppliers surgeons surgery symptoms Tara testimony tests Thank tion Traficant women with breast women with implants